News Articles


GDF11 - Magic or Myth?

GDF11_April17_2024.jpeg

GDF11, or Growth Differentiation Factor 11, rose to fame as a promising anti-aging molecule in 2013 when repletion in mice was shown to result in an age-related decline and reversal of cardiac hypertrophy (Loffredo, 2013). Subsequent studies further announced abilities to regenerate skeletal muscle and revascularize the brain (Sinha, 2014; Katsimpardi, 2014). In 2022, the biopharmaceutical company Elevian raised $58 million for GDF11 research, prompting a New York Times article titled "Can a 'Magic' Protein Slow the Aging Process?"..Read more


Different expression patterns in invasive and noninvasive PitNETs

Pitnet_April3_2024.PNG

In a study published in the Journal of the Endocrine Society, transcriptomics analysis and radiological evaluation was used to explore the differences between invasive and noninvasive pituitary neuroendocrine tumors (PitNETs) with respect to parasellar growth, bone invasiveness and vascularization...Read more


Exploring CLOCK: Our Inner Timekeeper

CLOCK_March27.jpeg

Our cells contain tiny molecular clocks that control a multitude of physiological and behavioral processes according to the circadian rhythm. Governed by a central clock, residing in the suprachiasmic nucleus of the brain, peripheral clocks are present in almost all tissues and organs (Hastings et al., 2003). They are, though able to persist in the absence of environmental cues, driven by the 24-hour patterns of light and temperature produced by the earth´s rotation, and periodically regulate functions such as body temperature, blood pressure, circulating hormones and metabolism (Mazzoccoli et al., 2012)...Read more


Young researcher awarded large grant for FTD research

emma.jpg

The postdoc Emma Gerrits in Jan Mulders HPA related research group at KI has recently, as the youngest person ever, received a 1.2 MSEK grant from Alzheimerfonden for research on the development of Frontotemporal dementia (FTD)...Read more


Altered plasma protein profiles in genetic FTD

FTD_Feb28_2024.PNG

In a study published in Molecular Neurodegeneration an international group of scientists including researchers from KTH have used a multiplex plasma profiling assay and a well-described genetic frontotemporal dementia (FTD) cohort collected within the GENFI study to explore potential plasma biomarkers that could reflect the pathology of this disease...Read more